Mycoplasma Pneumoniae Igm Antibodies

Mycoplasma pneumoniae IgM Antibodies

What it is

The Mycoplasma pneumoniae IgM Antibodies test detects IgM class antibodies in the blood that develop early in response to infection with Mycoplasma pneumoniae, a bacterium that commonly causes atypical pneumonia (also called “walking pneumonia”). IgM antibodies usually appear within the first week of illness, making this test useful for identifying recent or active infection.

Uses

This test is used to diagnose acute or recent infection with Mycoplasma pneumoniae. It helps distinguish between active disease and past exposure (which is usually assessed with IgG testing). It may also be performed during outbreaks of respiratory illness to confirm the cause.

Symptoms That May Lead to the Test

Doctors may order this test if you have symptoms of atypical pneumonia or persistent respiratory infection, such as prolonged cough, sore throat, chest discomfort, fever, fatigue, shortness of breath, or headache. It may also be recommended when other common bacterial or viral causes of pneumonia are excluded.

Abnormal Results

Positive IgM: Indicates a recent or active infection with Mycoplasma pneumoniae. It is most reliable during the first few weeks of illness, but false positives may occur and should be interpreted with clinical findings.

Negative IgM: Suggests no recent infection. However, if symptoms persist, additional testing (such as repeat serology, IgG, or PCR for Mycoplasma DNA) may be required, as IgM levels can wane or sometimes fail to appear in reinfections.

Risks

This is a simple blood test with minimal risks, including mild bruising, slight pain, or dizziness at the site of blood draw. These effects are temporary and harmless.